RxDoctor Payments Data

Toni-Ann Williams

Psychiatric/Mental Health · Dallas, TXNPI 1033813852

Payments from drug & device makers

$3,340in general payments, 2019–2025

Across 161 payments — averaging $20.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$432
  • Corium, LLC$380
  • AbbVie$351
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$331
  • Otsuka America Pharmaceutical, Inc.$322
  • Neurocrine Biosciences, Inc.$270
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$3,340100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,340 in reported general payments places this provider in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate12$22,314
Paliperidone ErPaliperidone13$2,551
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl17$1,144
Duloxetine Hcl29$969
Desvenlafaxine Succinate ErDesvenlafaxine Succinate19$969
Trazodone Hcl68$779
Buspirone Hcl39$759
Bupropion XlBupropion Hcl35$754
Quetiapine Fumarate20$533
Hydroxyzine Hcl23$509
Aripiprazole18$443
Sertraline Hcl40$431
Gabapentin28$375
Lamotrigine36$331
Prazosin Hcl15$310

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$331$22,31412 claims
Almatica Pharma LLCSertraline Hcl$41$43140 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →